MOMENTUM Country and Global Leadership program (MCGL-USAID): Contributing to sustainably reducing maternal, newborn, and child mortality and morbidity, and mitigating the impact of the COVID-19 pandemic.
ASSESSING ROUTINE IMMUNIZATION IN THE ERA OF COVID-19 IN PARTNERSHIP WITH THE WORLD HEALTH ORGANIZATION
The Challenge
MOMENTUM Country and Global Leadership (The Project), is a five-year large global project, part of a suite of innovative awards funded by the U.S. Agency for International Development (USAID) to holistically improve family planning and maternal and child health, including immunization in partner countries around the world. The project focuses on technical and capacity development assistance (TCDA) to ministries of health and other country partners to improve health outcomes. Led by Jhpiego, with IVAC and Save the Children as two core partners in addition to ten other implementing partners, the project aims to achieve:
- Scaled up and sustained access to and use of evidence-based, high-quality Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health (MNCH/FP/RH) information, health care, and interventions
- Accelerated reductions in maternal, newborn, and child mortality and morbidity in USAID partner countries
Increased adaptive learning and use of evidence in MNCH/FP/ FH programming through sustained partner country technical leadership - Improved capacity of partner country institutions
- Increased cross-sectoral collaboration and innovative partnerships between MNCH/FP/RH and non-MNCH/FP/RH organizations
Approach
MCGL uses a three-pronged approach to contribute to improving the coverage, equity and quality of immunization services and outcomes in the USAID priority countries. The first prong entails the development of global goods – such as the IA2030 Scorecard, developed in partnership with the WHO, US CDC and others to track progress, and drive accountability towards achieving IA2030 immunization goals and targets. It also entails, the promotion of global technical leadership in immunization. MCGL contributes thought leadership as active members of global working groups such as the IA2030 coordinating committee, the Gavi CSO constituency steering committee (CSO representative to the WHO SAGE), the urban immunization working group and the IA2030 SP 5 working group.
The second prong of our approach entails knowledge synthesis and data analytics to drive strategic and programmatic decision-making by global and country immunization stakeholders. Our knowledge synthesis portfolio includes systematic reviews of immunization systems disruption following COVID-19, COVID vaccine roll out experiences and learnings, HPV integration with adolescent health services, integration of immunization with primary health care interventions, and the role of faith actors in immunization. Our analytics portfolio includes multi-country analysis of zero dose and missed opportunity for vaccination.
The third prong of our approach is country-facing with targeted technical assistance and implementation support for a range of critical and catalytic interventions on COVID-19 vaccination and routine immunization e.g., assessment of the drivers of COVID vaccine hesitancy and acceptance; and the development of National Immunization Strategy, frontline provider’s job aids, VPD predictive model, and the ZDROP tool. MCGL has footprints in Madagascar, Tanzania, Zambia, India, and Haiti promoting integrated, person-centered solutions to address the problems of zero dose, birth dose, urban immunization and missed opportunity for vaccination, using insights from key informant interviews and human-centered design workshops.
[Immunization Agenda 2030 Scorecard] 2022 Data Launch: Social Media Toolkit
Project Contacts
Chizoba Wonodi: cwonodi1@jhu.edu
Anita Shet: ashet1@jhu.edu